Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Quarterly Report · 10-Q

Zimmer Biomet Holdings, Inc.

ZBHNYSEEQUITYCurrent

Quarterly Report

Filed Aug 5, 2026Accepted Aug 5, 2026, 4:06 PM EDTCIK 1136869Accession 0001193125-26-335044
Share

Company context

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.

Current securities

Recent company filings

  1. 144 filingSep 11, 2026
  2. 4 filingSep 9, 2026
  3. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureSep 8, 2026
  4. 144 filingSep 4, 2026
  5. SCHEDULE 13G - filed by Capital International Investors regarding ZIMMER BIOMET HOLDINGS, INC.Aug 12, 2026

Registered securities in this filing

ZIMMER BIOMET HOLDINGS, INC. · 10-Q · Filed 2026-08-05

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, $0.01 par value

Symbol
ZBH
Exchange
NYSE
Classification
COMMON
Status
Current
Filing context

Context: C_50443efb-29f0-4d78-8768-d0f898dc8e32

Dimensions: us-gaap:StatementClassOfStockAxis

2.425% Notes due 2026

Symbol
ZBH 26
Exchange
NYSE
Classification
DEBT
Filing context

Context: C_c2603873-0e32-4f0c-bed2-966da63f4334

Dimensions: us-gaap:StatementClassOfStockAxis

1.164% Notes due 2027

Symbol
ZBH 27
Exchange
NYSE
Classification
DEBT
Filing context

Context: C_d2fe6782-84f7-4dbe-83f3-6ab26736d010

Dimensions: us-gaap:StatementClassOfStockAxis

3.518% Notes due 2032

Symbol
ZBH 32
Exchange
NYSE
Classification
DEBT
Filing context

Context: C_be5d8bea-c990-45c1-8dd5-e7b34fa1df1e

Dimensions: us-gaap:StatementClassOfStockAxis

Accession 000119312526335044 · 4 registered-security cover members

Read the exact SEC filing ↗

As-filed source

Primary evidence

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.